Rep. Katie Porter @RepKatiePorter
I agree with @POTUS' call to action for lowering drug prices: "There is a difference between developing clinical breakthroughs and driving up prices for the drugs Americans rely on." REMINDER: Big Pharma spends more on stock buybacks to enrich shareholders than they do on R&D. — PolitiTweet.org
Rep. Katie Porter @RepKatiePorter
Big Pharma says they need to charge astronomical prices to pay for research and development. Yet, the amount they s… https://t.co/FF7lMiDjQ0